Cholesterol Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol
Condition:   Elevated Low-Density Lipoprotein Cholesterol Interventions:   Drug: SNK-396 - SAD cohort;   Drug: SNK-396 - MAD Cohort Sponsors:   Syneos Health;   SynerK Pharmatech (Suzhou) Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2023 Category: Research Source Type: clinical trials